Koninklijke Philips NV PHG shares are trading lower by 12.16% at $26.65 after the company reported first-quarter financial results.
Among the highlights from the first quarter, Koninklijke Philips highlighted:
- Group sales amounted to EUR 3.9 billion, with a 4% comparable sales decline on the back of 9% comparable sales growth in Q1 2021
- Comparable order intake increased 5%, driven by the Diagnosis & Treatment businesses and Hospital Patient Monitoring
- Income from continuing operations amounted to a loss of EUR 152 million, compared to a loss of EUR 34 million in Q1 2021
- Adjusted EBITA of EUR 243 million, or 6.2% of sales, compared to 9.5% of sales in Q1 2021
- Operating cash flow was an outflow of EUR 227 million, compared to an inflow of EUR 321 million in Q1 2021
See Also: Why Axsome Therapeutics Stock Is Falling Today
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care and personal health.
According to data from Benzinga Pro, Koninklijke Philips has a 52-week high of 61.23 and a 52-week low of $26.38.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in